Clinical trial
Longitudinal Cohort of Thrombosis and Hemostasis Diseases
NCT06727669 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Longitudinal Cohort of Thrombosis and Hemostasis Diseases
- Lead sponsor
- Peking University People's Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 1, 2024
- Completion date
- December 31, 2030
- Enrollment
- 3,000 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
arterial thromboembolism, bleeding disorder, coagulation factor deficiency, deep vein thrombosis, disseminated intravascular coagulation, hemophilia a, hemophilia a, acquired, hemophilia b, hemophilia b, acquired, immune thrombocytopenia, platelet dysfunction, pulmonary embolism, thrombophilia, thrombosis, thrombotic microangiopathies, thrombotic thrombocytopenic purpura